These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32291379)

  • 21. A novel dephosphorylation targeting chimera selectively promoting tau removal in tauopathies.
    Zheng J; Tian N; Liu F; Zhang Y; Su J; Gao Y; Deng M; Wei L; Ye J; Li H; Wang JZ
    Signal Transduct Target Ther; 2021 Jul; 6(1):269. PubMed ID: 34262014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silencing PP2A inhibitor by lenti-shRNA interference ameliorates neuropathologies and memory deficits in tg2576 mice.
    Liu GP; Wei W; Zhou X; Shi HR; Liu XH; Chai GS; Yao XQ; Zhang JY; Peng CX; Hu J; Li XC; Wang Q; Wang JZ
    Mol Ther; 2013 Dec; 21(12):2247-57. PubMed ID: 23922015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin deprivation induces PP2A inhibition and tau hyperphosphorylation in hTau mice, a model of Alzheimer's disease-like tau pathology.
    Gratuze M; Julien J; Petry FR; Morin F; Planel E
    Sci Rep; 2017 Apr; 7():46359. PubMed ID: 28402338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Over expression of PPP2R2C inhibits human glioma cells growth through the suppression of mTOR pathway.
    Fan YL; Chen L; Wang J; Yao Q; Wan JQ
    FEBS Lett; 2013 Dec; 587(24):3892-7. PubMed ID: 24126060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of Protein Phosphatase-2A (PP2A) by I1PP2A Leads to Hyperphosphorylation of Tau, Neurodegeneration, and Cognitive Impairment in Rats.
    Wang X; Blanchard J; Tung YC; Grundke-Iqbal I; Iqbal K
    J Alzheimers Dis; 2015; 45(2):423-35. PubMed ID: 25589718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morroniside-Induced PP2A Activation Antagonizes Tau Hyperphosphorylation in a Cellular Model of Neurodegeneration.
    Yang CC; Kuai XX; Gao WB; Yu JC; Wang Q; Li L; Zhang L
    J Alzheimers Dis; 2016; 51(1):33-44. PubMed ID: 26836014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substrate-specific reduction of PP2A activity exaggerates tau pathology.
    Deters N; Ittner LM; Götz J
    Biochem Biophys Res Commun; 2009 Feb; 379(2):400-5. PubMed ID: 19126401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SET SUMOylation promotes its cytoplasmic retention and induces tau pathology and cognitive impairments.
    Qin M; Li H; Bao J; Xia Y; Ke D; Wang Q; Liu R; Wang JZ; Zhang B; Shu X; Wang X
    Acta Neuropathol Commun; 2019 Feb; 7(1):21. PubMed ID: 30767764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure of a protein phosphatase 2A holoenzyme: insights into B55-mediated Tau dephosphorylation.
    Xu Y; Chen Y; Zhang P; Jeffrey PD; Shi Y
    Mol Cell; 2008 Sep; 31(6):873-85. PubMed ID: 18922469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diversity, developmental regulation and distribution of murine PR55/B subunits of protein phosphatase 2A.
    Schmidt K; Kins S; Schild A; Nitsch RM; Hemmings BA; Götz J
    Eur J Neurosci; 2002 Dec; 16(11):2039-48. PubMed ID: 12473071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of the 5'-AMP-Activated Protein Kinase in the Cerebral Cortex of Young Senescence-Accelerated P8 Mice and Association with GSK3β- and PP2A-Dependent Inhibition of p-tau₃₉₆ Expression.
    Kim HS; Moon S; Paik JH; Shin DW; Kim LS; Park CS; Ha J; Kang JH
    J Alzheimers Dis; 2015; 46(1):249-59. PubMed ID: 25737046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dysregulation of Exosome Cargo by Mutant Tau Expressed in Human-induced Pluripotent Stem Cell (iPSC) Neurons Revealed by Proteomics Analyses.
    Podvin S; Jones A; Liu Q; Aulston B; Ransom L; Ames J; Shen G; Lietz CB; Jiang Z; O'Donoghue AJ; Winston C; Ikezu T; Rissman RA; Yuan S; Hook V
    Mol Cell Proteomics; 2020 Jun; 19(6):1017-1034. PubMed ID: 32295833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of asparaginyl endopeptidase leads to Tau hyperphosphorylation in Alzheimer disease.
    Basurto-Islas G; Grundke-Iqbal I; Tung YC; Liu F; Iqbal K
    J Biol Chem; 2013 Jun; 288(24):17495-507. PubMed ID: 23640887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How it all started: tau and protein phosphatase 2A.
    Liu C; Götz J
    J Alzheimers Dis; 2013; 37(3):483-94. PubMed ID: 23948891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation.
    Liu F; Grundke-Iqbal I; Iqbal K; Gong CX
    Eur J Neurosci; 2005 Oct; 22(8):1942-50. PubMed ID: 16262633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel therapeutic strategies for neurodegenerative disease.
    Tanimukai H; Kudo T; Tanaka T; Grundke-Iqbal I; Iqbal K; Takeda M
    Psychogeriatrics; 2009 Jun; 9(2):103-9. PubMed ID: 19604333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulating Protein Phosphatase 2A Rescues Disease Phenotype in Neurodegenerative Tauopathies.
    McKenzie-Nickson S; Chan J; Perez K; Hung LW; Cheng L; Sedjahtera A; Gunawan L; Adlard PA; Hayne DJ; McInnes LE; Donnelly PS; Finkelstein DI; Hill AF; Barnham KJ
    ACS Chem Neurosci; 2018 Nov; 9(11):2731-2740. PubMed ID: 29920069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein phosphatase 2A activators reverse age-related behavioral changes by targeting neural cell senescence.
    Xing J; Chen K; Gao S; Pousse M; Ying Y; Wang B; Chen L; Wang C; Wang L; Hu W; Lu Y; Gilson E; Ye J
    Aging Cell; 2023 Mar; 22(3):e13780. PubMed ID: 36644807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C-glycosides analogues of the okadaic acid central fragment exert neuroprotection via restoration of PP2A-phosphatase activity: A rational design of potential drugs for Alzheimer's disease targeting tauopathies.
    Arribas RL; Viejo L; Bravo I; Martínez M; Ramos E; Romero A; García-Frutos EM; Janssens V; Montiel C; de Los Ríos C
    Eur J Med Chem; 2023 May; 251():115245. PubMed ID: 36905916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
    Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
    J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.